Aβ Aggregation inhibitors. Part 1: Synthesis and biological activity of phenylazo benzenesulfonamides
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (5) , 1173-1176
- https://doi.org/10.1016/j.bmcl.2003.12.086
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- The Challenge of Inhibiting Aβ PolymerizationCurrent Medicinal Chemistry, 2002
- Secretase Targets for Alzheimer's Disease: Identification and Therapeutic PotentialJournal of Medicinal Chemistry, 2001
- Imaging Alzheimer's amyloidNature Biotechnology, 2000
- Controlling Polymerization of β-Amyloid and Prion-derived Peptides with Synthetic Small Molecule LigandsJournal of Biological Chemistry, 2000
- A short synthesis of the β-amyloid (Aβ) aggregation inhibitor 3-p-Toluoyl-2-[4′-(3-diethylaminopropoxy)-phenyl]-benzofuranTetrahedron Letters, 1999
- Modified-Peptide Inhibitors of Amyloid β-Peptide PolymerizationBiochemistry, 1999
- Chapter 3. β-Amyloid as a Target for Alzheimer's Disease TherapyPublished by Elsevier ,1999
- Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.Proceedings of the National Academy of Sciences, 1994
- Development of small molecule probes for the Beta-amyloid protein of Alzheimer's DiseaseNeurobiology of Aging, 1994